“…CRISPR-Cas9 systems can be utilized in high-content/high-throughput screening to examine numerous effects; either performing focused screens or using a genome-wide gRNA library to enable genome-scale CRISPR-Cas9 knockout (GeCKO; Shalem et al, 2015). In this way, screens can examine changes in responses of cell cultures for drug discovery/resistance, bacterial toxin resistance, and validation of drug targets (Wang et al, 2014; Koike-Yusa et al, 2014; Zhou et al, 2014; Kasap et al, 2014; Shi et al, 2015; Smurnyy et al, 2014; Carlson-Stevermer et al, 2016; Hsu et al, 2014). Wei and colleagues demonstrated the advantages of high-throughput phenotypic screening based on the CRISPR/Cas9 system, utilizing single guide RNA (sgRNA) library transduced HeLa cells to identify novel genes related to anthrax and diphtheria toxin toxicity (Zhou et al, 2014)…”